C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/89 (2006.01) A61K 31/4427 (2006.01) A61P 11/00 (2006.01) C07D 213/64 (2006.01) C07D 213/76 (2006.01) C07D 213/79 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2369092
The invention encompasses the novel compound of Formula (I) useful in the treatment of diseases, including asthma, by raising the level of cyclic adenosine-3',5'-monophosphate (cAMP) through the inhibition of phosphodiesterase IV (PDE 4). The invention also encompasses pharmaceutical compositions and methods for treatment.
L'invention concerne un nouveau composé représenté par la formule (I) utilisé dans le traitement de maladies, y compris l'asthme, pour augmenter le niveau d'adénosine-3',5'-monophosphate (cAMP) cyclique par l'inhibition de phosphodiestérase IV (PDE 4). L'invention concerne également des compositions pharmaceutiques et des méthodes de traitement.
Frenette Richard
Friesen Richard
Girard Mario
Girard Yves
Godbout Cedrickx
Merck Frosst Canada & Co./merck Frosst Canada & Cie
Merck Frosst Canada Ltd.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Heterosubstituted pyridine derivatives as pde 4 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterosubstituted pyridine derivatives as pde 4 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterosubstituted pyridine derivatives as pde 4 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1658411